Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/1995
03/30/1995WO1995008347A1 Methods and products for controlling immune responses in mammals
03/30/1995WO1995008342A1 Dietary hypocholesterolaemic compositions comprising soya proteins and sitosterols
03/30/1995WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
03/30/1995WO1994028153A3 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
03/30/1995CA2172256A1 New bishispidine derivatives, processes for their production and pharmaceutical agents containing these compounds
03/29/1995EP0645378A1 Condensed seven- or eight-membered heterocyclic compounds useful as squalene synthetase inhibitors
03/29/1995EP0645377A1 Benzoxazepine derivatives useful as squalene synthetase inhibitors
03/29/1995EP0644898A1 Filamentous fungus proteins for binding and transporting lipids, preparation method therefor and use thereof
03/29/1995EP0644891A1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
03/29/1995EP0644760A1 Treatments for diseases characterized by neovascularization
03/29/1995EP0569411B1 Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases
03/29/1995CN1100724A 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them
03/28/1995US5401772 Heteroacetic acid derivatives
03/28/1995US5401498 Pharmaceuticals comprising polyhydroxymethylene derivatives, process for their preparation and use
03/28/1995CA1334972C Pyridine-2,4- and -2,5-dicarboxylic acid amides, processes for their preparation, the use thereof, and medicaments based on these compounds
03/28/1995CA1334936C Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
03/25/1995CA2132794A1 Condensed 7-membered cyclic compounds and their use
03/25/1995CA2132792A1 Condensed cyclic compounds and their use
03/23/1995WO1995007931A1 Acylated insulin
03/23/1995WO1995007898A1 Succinamic acid compound, process for producing the same, and use thereof
03/23/1995WO1995007701A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
03/23/1995WO1995007697A2 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
03/23/1995WO1995007694A1 Use of thiazolidinediones to prevent or delay onset of niddm
03/23/1995WO1995007632A1 Ready-to-eat cereals containing extruded pre-wetted psyllium
03/23/1995WO1995007631A1 Psyllium containing snack bars, processes for making these, and uses thereof
03/23/1995WO1995007627A1 Psyllium-enriched dough products and method for making the same
03/23/1995WO1995007626A1 Psyllium enriched pasta products and method for making same
03/23/1995WO1995005184A3 Phosphate-binding polymers for oral administration
03/23/1995CA2172038A1 Psyllium containing snack bars, processes for making these, and uses thereof
03/23/1995CA2172037A1 Psyllium-enriched dough products and method for making the same
03/23/1995CA2172036A1 Psyllium enriched pasta products and method for making same
03/23/1995CA2172035A1 Ready-to-eat cereals containing extruded pre-wetted psyllium
03/23/1995CA2171829A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
03/23/1995CA2171756A1 Succinamic acid compound, production method thereof and use thereof
03/23/1995CA2168751A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
03/22/1995EP0644194A1 Pyridothiazineacetic acid compound, process for producing the same, and use thereof
03/22/1995EP0643965A1 Nicotinic acid compositions for treating hyperlipidemia
03/22/1995EP0643716A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
03/22/1995EP0643690A1 Desferrioxamine-b salts and their use as orally effective iron chelators
03/22/1995EP0301087B1 Peptide
03/22/1995CN1100417A N-heteroaryl-n'-phenylurea derivatives, their production and use
03/21/1995US5399743 Osteoporosis, hypercalcemia
03/21/1995US5399675 Acidic polycyclic ether antibiotics and microorganisms useful in the production thereof
03/21/1995US5399573 Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract
03/21/1995US5399561 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity
03/21/1995US5399550 Physiologically active substance derived or malt and process for the production thereof
03/16/1995WO1995007292A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t
03/16/1995WO1995007284A1 Phosphinic acid derivatives with anti-hyper glycemic and/or anti-obesity activity
03/16/1995WO1995007258A1 Cyclohexanediurea derivative and process for producing the same
03/16/1995WO1995007098A1 Methods for regulating gastrointestinal motility
03/16/1995WO1995007091A1 Uses of vegetable oils
03/16/1995WO1995007080A1 A method of treating liver disease and like indications with vasodilating agents
03/16/1995WO1995007078A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
03/16/1995WO1995003405A3 Enzymatic method for modification of recombinant polypeptides
03/16/1995CA2171440A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
03/16/1995CA2171295A1 Cyclohexanediurea derivative and process for producing the same
03/16/1995CA2168561A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t
03/15/1995EP0643071A1 Compound for inhibiting bone resorption and accelerating osteogenesis
03/15/1995EP0643057A1 Inhibitors of microsomal triglyceride transfer protein
03/15/1995EP0642521A1 Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642520A1 Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642519A1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642518A1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
03/15/1995EP0642498A1 NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT)
03/15/1995EP0642350A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties
03/15/1995EP0573604B1 Methods for the treatment of osteoporosis
03/15/1995CN1027891C 5-substituted ornithine derivatives.
03/14/1995USRE34878 Hypoglycemic agent
03/14/1995US5397799 Anxiolytic agents, antidepressants
03/14/1995US5397798 Benzamide and sulfonamide hypoglycemic agents
03/14/1995US5397792 Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
03/14/1995US5397788 Antitumor agents, antiulcer agents, antipsychotics or anxiety
03/14/1995US5397781 Pyrimidine derivatives
03/14/1995US5397778 Enteral formulations for treatment of inflammation and infection
03/14/1995US5397775 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26,27-dimethylene-24-epi-1α,25-dihydroxyvitamin D2 and methods for preparing same
03/14/1995US5397591 Infant formula and baby food containing docosahexaenoic acid obtained from dinoflagellates
03/14/1995US5397576 Spray triturated micronutrient compositions
03/14/1995CA1334738C Methods and compositions for the treatment of niddm
03/09/1995WO1995006636A1 5-arylindole derivatives
03/09/1995WO1995006472A1 Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process
03/09/1995WO1995006471A1 Blood triglyceride lowering agent
03/09/1995WO1995006410A1 Treatment of chronic inflammatory diseases by angiotension ii receptor antagonists
03/09/1995DE3590020C2 1-Hydroxy-vitamin-D compounds which are unsaturated in the side chain
03/09/1995CA2148373A1 Delta 5-androstenes useful for promoting weight maintenance or weight loss and treatment process
03/08/1995EP0641792A1 1,2-Dithiole derivatives and therapeutic agents containing them
03/08/1995EP0641790A1 Tocopherols
03/08/1995EP0641345A1 Hypoglycemic n-sulfonyl-tetrahydro- 1,3]-dioxepino 5,6-b]azirines
03/08/1995EP0641338A1 Hypoglycemic thiazolidinediones and intermediates
03/08/1995EP0641331A1 Chiral intermediates for the preparation of antidiabetics thiazoles
03/08/1995EP0641214A1 Non-bitter protein hydrolyzates
03/08/1995EP0641201A1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids
03/08/1995EP0495013B1 Hexapeptides with sulphate ester groups
03/08/1995CN1099801A Peptides
03/08/1995CN1099759A 哌嗪衍生物 Piperazine derivatives
03/08/1995CN1099755A Cyclic derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/07/1995US5395957 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds
03/07/1995US5395848 Administering anticholesterol agent to mammals; atherosclerosis
03/07/1995US5395834 New benzopyran compounds
03/07/1995US5395830 Method of treating osteoporosis with 1α,24(R)-dihydroxy-22(E)-dehydro-vitamin D3
03/07/1995US5395826 Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use
1 ... 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 ... 1298